ROYAL BANK OF CANADA - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 26 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$39,000
+62.5%
5,841
+101.3%
0.00%
Q2 2023$24,000
+500.0%
2,901
+673.6%
0.00%
Q1 2023$4,000
-73.3%
375
-82.2%
0.00%
Q4 2022$15,000
+25.0%
2,112
-6.2%
0.00%
Q3 2022$12,000
+200.0%
2,252
+133.9%
0.00%
Q2 2022$4,000
-69.2%
963
-68.0%
0.00%
Q1 2022$13,000
-69.0%
3,008
-71.5%
0.00%
Q4 2021$42,000
+5.0%
10,557
+131.5%
0.00%
Q3 2021$40,000
-9.1%
4,560
+19.4%
0.00%
Q2 2021$44,000
+29.4%
3,818
+34.8%
0.00%
Q1 2021$34,000
+100.0%
2,832
+11.5%
0.00%
Q4 2020$17,000
-10.5%
2,5400.0%0.00%
Q3 2020$19,000
+11.8%
2,540
-39.8%
0.00%
Q2 2020$17,000
+112.5%
4,222
+27.5%
0.00%
Q1 2020$8,000
-66.7%
3,311
-19.3%
0.00%
Q4 2019$24,0004,102
+4310.8%
0.00%
Q3 2019$093
+132.5%
0.00%
Q2 2019$0400.0%0.00%
Q1 2019$0400.0%0.00%
Q4 2018$0
-100.0%
40
-86.8%
0.00%
Q3 2018$5,000
+400.0%
302
+36.0%
0.00%
Q2 2018$1,000222
+455.0%
0.00%
Q1 2018$040
-37.5%
0.00%
Q4 2017$064
+611.1%
0.00%
Q3 2017$09
+800.0%
0.00%
Q2 2017$010.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,015,668$25,301,45430.67%
Perceptive Advisors 11,350,085$95,227,2132.76%
JOHNSON & JOHNSON 394,834$3,312,6571.03%
Affinity Asset Advisors, LLC 150,000$1,258,5000.44%
Prosight Management, LP 299,022$2,508,7940.38%
Tri Locum Partners LP 73,067$613,0320.23%
WOODSTOCK CORP 137,179$1,150,9320.14%
Joseph P. Lucia & Associates, LLC 22,781$191,1330.13%
Palo Alto Investors LP 160,800$1,349,1120.11%
Verition Fund Management LLC 930,074$7,803,3210.10%
View complete list of ALDEYRA THERAPEUTICS INC shareholders